Nature Communications (Feb 2023)
A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma
Abstract
The blood-brain barrier represents a hurdle for the delivery of therapeutics in brain tumor tissues. Here the authors describe the design of a nitric oxide-driven nanomotor loaded with the glycolysis inhibitor lonidamine, breaking through the blood-brain barrier and eliciting anti-tumor immune responses in preclinical models of glioblastoma.